The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models

Timo Minssen; Effy Vayena; I Glenn Cohen

doi:10.1001/jama.2023.9651

The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models

JAMA. 2023 Jul 25;330(4):315-316. doi: 10.1001/jama.2023.9651.

Authors

Timo Minssen^{1

2}, Effy Vayena³, I Glenn Cohen⁴

Affiliations

¹ Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Copenhagen, Denmark.
² Centre for Law, Medicine, and Life Sciences, University of Cambridge, Cambridge, England.
³ Institute of Translational Medicine, Swiss Federal Institute of Technology Zurich (ETH Zurich), Zurich, Switzerland.
⁴ Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, Massachusetts.

PMID: 37410482
DOI: 10.1001/jama.2023.9651

No abstract available

Plain language summary

This Viewpoint discusses how regulators across the world should approach the legal and ethical challenges, including privacy, device regulation, competition, intellectual property rights, cybersecurity, and liability, raised by the medical use of large language models.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Artificial Intelligence* / legislation & jurisprudence
Health Communication* / methods
Language
Legislation, Medical*
Ownership / legislation & jurisprudence
Privacy* / legislation & jurisprudence